We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About BillionToOne Stock

Invest in or calculate the value of your shares in BillionToOne or other pre-IPO companies through EquityZen's platform.

Get Started

BillionToOne Stock (BIIT)

BillionToOne is a precision diagnostics company that makes molecular diagnostics accurate, efficient, and accessible for all.

About BillionToOne Stock

Founded

2016

Headquarters

Menlo Park, CA, US

Industries

Software, Artificial Intelligence, Data and Analytics

BillionToOne is a precision diagnostics company that quantifies biology to create molecular diagnostics accurate, efficient, and accessible for all. The company's patent-pending molecular counter platform is a technology platform that can accurately count the DNA molecules to the single-count level. BillionToOne's mission is to make pre-natal testing safe and affordable for every expecting mother. Its novel technology can detect even single-gene disorders such as thalassemia through a simple blood test. They are replacing amniocentesis, an invasive and risky procedure that has a high miscarriage risk, with a safe and affordable blood test, starting with developing countries. BillionToOne was founded in 2016 and is headquartered in Menlo Park, California.

BillionToOne Management

Leadership team at BillionToOne

Co-Founder

Oguzhan Atay

CTO

David Tsao

Locked Features

Join now and verify your accreditation status to gain access to:

  • BillionToOne current valuation
  • BillionToOne stock price
  • Available deals in BillionToOne and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in BillionToOne stock?

Accredited investors can buy pre-IPO stock in companies like BillionToOne through EquityZen funds. These investments are made available by existing BillionToOne shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell BillionToOne stock?

Shareholders can sell their BillionToOne stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."